学术探索
学术期刊
新闻热点
数据分析
智能评审

What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?

被引：7
作者：
Dickstein, K [1 ]
机构：
[1] Univ Bergen, Cent Hosp Rogaland, Stavanger, Norway
来源：
AMERICAN HEART JOURNAL | 2003年 / 145卷 / 05期
关键词：
ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; HEART-FAILURE; MORTALITY; MORBIDITY; LOSARTAN; CAPTOPRIL; VALSARTAN; SURVIVAL;
D O I：
10.1016/S0002-8703(03)00168-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：754 / 757
页数：4
相关论文
共 21 条
  • [1] ABBAS A, 1999, AM HEART J, V138, P1133
  • [2] THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION
    AMBROSIONI, E
    BORGHI, C
    MAGNANI, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) : 80 - 85
  • [3] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [4] DESMOPRESSIN AND BLOOD-LOSS AFTER CARDIAC-SURGERY
    CATTANEO, M
    MANNUCCIO, P
    MANNUCCI
    [J]. LANCET, 1993, 342 (8874) : 812 - 812
  • [5] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    Cohn, JN
    Tognoni, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1667 - 1675
  • [6] COLLINS R, 1995, LANCET, V345, P669
  • [7] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    [J]. LANCET, 2002, 359 (9311) : 995 - 1003
  • [8] DEVITA C, 1994, LANCET, V343, P1115
  • [9] Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
    Dickstein, K
    Kjekshus, J
    [J]. LANCET, 2002, 360 (9335) : 752 - 760
  • [10] Indications for ACE inhibitors in the early treatment of acute myocardial infarction -: Systematic overview of individual data from 100,000 patients in randomized trials
    Franzosi, MG
    Santoro, E
    Zuanetti, G
    Baigent, C
    Collins, R
    Flather, M
    Kjekshus, J
    Latini, R
    Liu, LS
    Maggioni, AP
    Sleight, P
    Swedberg, K
    Tognoni, G
    Yusuf, S
    Tavazzi, L
    Ball, S
    Kober, L
    Torp-Pedersen, C
    Braunwald, E
    Moyé, L
    Pfeffer, M
    Santoro, L
    Pogue, J
    Wang, Y
    [J]. CIRCULATION, 1998, 97 (22) : 2202 - 2212
123